CD7+ T-ALL/LBL

Clinical trials for CD7+ T-ALL/LBL explained in plain language.

Never miss a new study

Get alerted when new CD7+ T-ALL/LBL trials appear

Sign up with your email to follow new studies for CD7+ T-ALL/LBL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Experimental CAR-T therapy targets tough childhood blood cancers

Disease control Not yet recruiting

This early-phase trial is testing a new treatment called PA3-17 injection for children and teens aged 3 to 18 with T-cell leukemia or lymphoma that has not responded to standard therapy or has come back. The treatment uses the patient's own immune cells, modified to recognize and…

Matched conditions: CD7+ T-ALL/LBL

Phase: PHASE1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

CD7+ T-ALL/LBL

Get alerted when new CD7+ T-ALL/LBL trials appear

Experimental CAR-T therapy targets tough childhood blood cancers